Literature DB >> 24829248

Set of classical PCRs for detection of mutations in Candida glabrata FKS genes linked with echinocandin resistance.

Catiana Dudiuk1, Soledad Gamarra2, Florencia Leonardeli2, Cristina Jimenez-Ortigosa3, Roxana G Vitale4, Javier Afeltra5, David S Perlin3, Guillermo Garcia-Effron6.   

Abstract

Clinical echinocandin resistance among Candida glabrata strains is increasing, especially in the United States. Antifungal susceptibility testing is considered mandatory to guide therapeutic decisions. However, these methodologies are not routinely performed in the hospital setting due to their complexity and the time needed to obtain reliable results. Echinocandin failure in C. glabrata is linked exclusively to Fks1p and Fks2p amino acid substitutions, and detection of such substitutions would serve as a surrogate marker to identify resistant isolates. In this work, we report an inexpensive, simple, and quick classical PCR set able to objectively detect the most common mechanisms of echinocandin resistance in C. glabrata within 4 h. The usefulness of this assay was assessed using a blind collection of 50 C. glabrata strains, including 16 FKS1 and/or FKS2 mutants.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24829248      PMCID: PMC4097693          DOI: 10.1128/JCM.01038-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1.

Authors:  Sergey V Balashov; Steven Park; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

2.  Multiplex detection of mutations.

Authors:  David S Perlin; Sergey Balashov; Steven Park
Journal:  Methods Mol Biol       Date:  2008

3.  Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.

Authors:  John D Cleary; Guillermo Garcia-Effron; Stanley W Chapman; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191

Review 4.  Resistance to echinocandin-class antifungal drugs.

Authors:  David S Perlin
Journal:  Drug Resist Updat       Date:  2007-06-13       Impact factor: 18.500

5.  Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility.

Authors:  Santosh Katiyar; Michael Pfaller; Thomas Edlind
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

Review 6.  Global trends in the distribution of Candida species causing candidemia.

Authors:  J Guinea
Journal:  Clin Microbiol Infect       Date:  2014-03-06       Impact factor: 8.067

7.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

Authors:  S Ascioglu; J H Rex; B de Pauw; J E Bennett; J Bille; F Crokaert; D W Denning; J P Donnelly; J E Edwards; Z Erjavec; D Fiere; O Lortholary; J Maertens; J F Meis; T F Patterson; J Ritter; D Selleslag; P M Shah; D A Stevens; T J Walsh
Journal:  Clin Infect Dis       Date:  2001-11-26       Impact factor: 9.079

8.  Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.

Authors:  David L Horn; Dionissios Neofytos; Elias J Anaissie; Jay A Fishman; William J Steinbach; Ali J Olyaei; Kieren A Marr; Michael A Pfaller; Chi-Hsing Chang; Karen M Webster
Journal:  Clin Infect Dis       Date:  2009-06-15       Impact factor: 9.079

9.  Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection.

Authors:  George R Thompson; Nathan P Wiederhold; Ana C Vallor; Nyria C Villareal; James S Lewis; Thomas F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2008-08-01       Impact factor: 5.191

10.  Rapid detection of triazole antifungal resistance in Aspergillus fumigatus.

Authors:  Guillermo Garcia-Effron; Amanda Dilger; Laura Alcazar-Fuoli; Steven Park; Emilia Mellado; David S Perlin
Journal:  J Clin Microbiol       Date:  2008-01-30       Impact factor: 5.948

View more
  14 in total

1.  Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance.

Authors:  Chayanika Biswas; Sharon C-A Chen; Catriona Halliday; Elena Martinez; Rebecca J Rockett; Qinning Wang; Verlaine J Timms; Rajat Dhakal; Rosemarie Sadsad; Karina J Kennedy; Geoffrey Playford; Deborah J Marriott; Monica A Slavin; Tania C Sorrell; Vitali Sintchenko
Journal:  J Vis Exp       Date:  2017-12-28       Impact factor: 1.355

2.  Antifungal Activity of SCY-078 and Standard Antifungal Agents against 178 Clinical Isolates of Resistant and Susceptible Candida Species.

Authors:  Wiley A Schell; A M Jones; Katyna Borroto-Esoda; Barbara D Alexander
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

3.  Rapid Detection of FKS-Associated Echinocandin Resistance in Candida glabrata.

Authors:  Yanan Zhao; Yoji Nagasaki; Milena Kordalewska; Ellen G Press; Ryan K Shields; M Hong Nguyen; Cornelius J Clancy; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

4.  Phenotypic and Molecular Evaluation of Echinocandin Susceptibility of Candida glabrata, Candida bracarensis, and Candida nivariensis Strains Isolated during 30 Years in Argentina.

Authors:  Soraya Morales-López; Catiana Dudiuk; Walter Vivot; Wanda Szusz; Susana B Córdoba; Guillermo Garcia-Effron
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

Review 5.  Clinical perspectives on echinocandin resistance among Candida species.

Authors:  Ryan K Shields; M Hong Nguyen; Cornelius J Clancy
Journal:  Curr Opin Infect Dis       Date:  2015-12       Impact factor: 4.915

Review 6.  Echinocandin resistance: an emerging clinical problem?

Authors:  Maiken C Arendrup; David S Perlin
Journal:  Curr Opin Infect Dis       Date:  2014-12       Impact factor: 4.915

7.  Resistance to Echinocandins in Candida Can Be Detected by Performing the Etest Directly on Blood Culture Samples.

Authors:  Pilar Escribano; Jesús Guinea; María Ángeles Bordallo-Cardona; Laura Judith Marcos-Zambrano; Carlos Sánchez-Carrillo; Emilio Bouza; Patricia Muñoz
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

Review 8.  Recent trends in molecular diagnostics of yeast infections: from PCR to NGS.

Authors:  Toni Gabaldón
Journal:  FEMS Microbiol Rev       Date:  2019-09-01       Impact factor: 16.408

Review 9.  Responding to the emergence of antifungal drug resistance: perspectives from the bench and the bedside.

Authors:  Justin Beardsley; Catriona L Halliday; Sharon C-A Chen; Tania C Sorrell
Journal:  Future Microbiol       Date:  2018-08-16       Impact factor: 3.165

10.  Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait.

Authors:  Zahraa F Al-Baqsami; Suhail Ahmad; Ziauddin Khan
Journal:  Sci Rep       Date:  2020-04-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.